ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,438Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 1844

$1.66M Total Retail Price of All Prescriptions

Rank: 8 out of 1844

752 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 752 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 752 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 21,660 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 1,063 863 1 1
OMEPRAZOLE 1,037 816 2 5
SIMVASTATIN 987 812 3 3
FUROSEMIDE 981 806 4 7
DONEPEZIL HCL 762 722 5 26
LISINOPRIL 746 614 6 4
WARFARIN SODIUM 701 600 7 13
TRAMADOL HCL 694 503 8 18
NAMENDA 685 650 9 33
AMLODIPINE BESYLATE 595 469 10 6
METOPROLOL TARTRATE 585 470 11 11
POTASSIUM CHLORIDE 492 411 12 16
HYDROCODONE-ACETAMINOPHEN 446 311 S3 13 2
ESCITALOPRAM OXALATE 401 321 14 52
GABAPENTIN 351 216 15 15
PANTOPRAZOLE SODIUM 350 291 16 32
CITALOPRAM HBR 348 302 17 19
METOPROLOL SUCCINATE 299 249 18 14
LANTUS 291 166 19 42
SERTRALINE HCL 285 254 20 21
POLYETHYLENE GLYCOL 3350 283 241 21 39
METFORMIN HCL 274 182 22 8
QUETIAPINE FUMARATE 268 234 23 82
RISPERIDONE 246 225 24 65
LEVOFLOXACIN 243 198 25 78
DIVALPROEX SODIUM 238 186 26 74
MIRTAZAPINE 237 237 27 49
TAMSULOSIN HCL 231 222 28 27
CARVEDILOL 221 187 29 22
CYMBALTA 208 129 30 36
ALENDRONATE SODIUM 197 180 31 25
ATORVASTATIN CALCIUM 189 155 32 12
DIGOXIN 188 162 33 67
KLOR-CON M20 188 113 33 54
EXELON 187 187 35 112
PRAVASTATIN SODIUM 183 154 36 10
NOVOLOG 182 101 37 84
CARBIDOPA-LEVODOPA 180 168 38 86
LIDODERM 178 140 39 155
ISOSORBIDE MONONITRATE ER 168 157 40 59
CLOPIDOGREL 166 131 41 34
TRIAMCINOLONE ACETONIDE 164 126 42 153
LEVETIRACETAM 157 60 43 105
ATENOLOL 156 149 44 17
NOVOLIN R 154 109 45 214
IPRATROPIUM-ALBUTEROL 151 136 46 113
TRAZODONE HCL 147 112 47 43
NYSTATIN 147 107 47 85
OLANZAPINE 133 59 49 117
MELOXICAM 128 73 50 28
CEPHALEXIN 126 89 51 56
GLIPIZIDE 126 115 51 70
HYDROCHLOROTHIAZIDE 124 99 53 9
JANUVIA 120 84 54 77
LOSARTAN POTASSIUM 114 112 55 24
SYMBICORT 113 96 56 134
SEROQUEL 113 112 56 191
RANITIDINE HCL 112 104 58 38
NYSTOP 109 81 59 185
CLONIDINE HCL 108 55 60 64
PLAVIX 108 84 60 61
FINASTERIDE 108 96 60 137
ABILIFY 105 69 63 150
FENTANYL 104 73 S2 64 66
PREDNISONE 102 89 65 40
CARBAMAZEPINE 100 68 66 204
SPIRIVA 98 76 67 57
IBUPROFEN 98 86 67 89
OXYBUTYNIN CHLORIDE 97 85 69 103
ALLOPURINOL 92 75 70 29
RAMIPRIL 91 88 71 116
LEXAPRO 90 76 72 179
ROPINIROLE HCL 90 67 72 76
SULFAMETHOXAZOLE-TRIMETHOPRIM 87 74 74 73
NITROGLYCERIN PATCH 84 72 75 173
ZOLPIDEM TARTRATE 82 69 76 23
ARICEPT 81 81 77 275
FAMOTIDINE 81 66 77 63
AMIODARONE HCL 80 65 79 208
FLUOXETINE HCL 80 49 79 41
NOVOLIN 70-30 80 50 79 248
PROMETHAZINE HCL 79 46 R 82 88
PAROXETINE HCL 78 71 83 68
CLOTRIMAZOLE-BETAMETHASONE 76 43 84 202
OXYBUTYNIN CHLORIDE ER 74 71 85 126
HYDROXYZINE HCL 74 43 R 85 164
BACLOFEN 70 0 87 119
ADVAIR DISKUS 70 64 87 51
KLOR-CON M10 69 53 89 149
NEXIUM 68 28 90 31
HUMALOG 65 53 91 114
LATANOPROST 64 59 92 250
DILTIAZEM 24HR CD 62 62 93 132
SPIRONOLACTONE 61 37 94 60
METOCLOPRAMIDE HCL 57 22 95 148
METHOTREXATE 56 35 96 292
GLIPIZIDE ER 56 42 96 79
ALBUTEROL SULFATE 56 27 96 115
CIPROFLOXACIN HCL 54 46 99 62
COMBIVENT 54 40 99 131
VESICARE 54 45 99 182
DIOVAN 53 53 102 58
CELEBREX 53 43 102 91
CLONIDINE 52 31 104 264
BENZTROPINE MESYLATE 51 39 R 105 201
LOPERAMIDE 51 46 105 216
PHENYTOIN SODIUM EXTENDED 50 26 107 147
VENLAFAXINE HCL ER 50 29 107 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 6, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.